Glipizide
- Product NDC
- 59651-268
- 11-digit product format
- 596510268
- Labeler code
- 59651
- Product ID
- 59651-268_17329bb9-0057-451a-8621-d6319d8939bd
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Glipizide
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Aurobindo Pharma Limited
- Application
- ANDA206928
- Marketing category
- ANDA
- Marketing start
- 2017-05-12
- Marketing end
- 0000-00-00
- Substance
- GLIPIZIDE
- Active strength
- 3 mg/1
- Pharmacologic classes
- Sulfonylurea Compounds [CS], Sulfonylurea [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Additional Listing Data#
- Finished product
- No
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| GLIPIZIDE | 2.5 mg/1 |
DailyMed Product Concepts#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 59651-268 | GLIPIZIDE TABLET, EXTENDED RELEASE [AUROBINDO PHARMA LIMITED] | 6 | Legacy NDC | 20230606_9ace98c0-1115-4157-b611-fee4c915a8bf.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 59651-268-30 | 59651026830 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (59651-268-30) | 2017-05-12 | 0000-00-00 | No | No | Current |
| 59651-268-71 | 59651026871 | 7000 TABLET, EXTENDED RELEASE in 1 BAG (59651-268-71) | 12-MAY-17 | | | | Current |